By DAVID McHUGHAP Business Writer
FRANKFURT, Germany (AP) - German engineering company Siemens is appointing the co-CEO of business software maker SAP to its board of directors to replace Josef Ackermann, who resigned in the wake of the board's decision to push out chief executive Peter
By JOSHUA FREEDAP Business Writer
Stocks closed mostly lower Friday after investors found little to like in weak corporate earnings reports and news of only tepid growth in the U.S. economy in the third quarter.
The Dow Jones industrial average managed a gain of 3.53 points to close at 13,107.
By PHILIP ELLIOTTAssociated Press
LORDSTOWN, Ohio (AP) - President Barack Obama's decision to help America's automakers could end up being what helps drive him back into the White House.
Some 850,000 jobs in this critical battleground state are tied to autos and Obama's campaign
By TOBY STERLINGAssociated Press
AMSTERDAM (AP) - Royal Philips Electronics NV, the maker of electric shavers, light bulbs and medical imaging equipment, saw earnings more than double in the third quarter, thanks to modest growth at all its business lines as well as the disposal of its loss-
By GILLIAN FLACCUS and KRISTEN WYATTAssociated Press
AURORA, Colo. (AP) - A U.S. Navy veteran who served three tours of duty in the Middle East. A 6-year-old girl excited about learning to swim. A Target employee who shielded his girlfriend and her brother with his own body. They and nine
By FRANK JORDANSAssociated Press
BERLIN (AP) - Scientists working at the world's biggest atom smasher near Geneva have announced the discovery of a new subatomic particle that looks remarkably like the long-sought Higgs boson. Sometimes called the "God particle" because its
By JOHN HEILPRINAssociated Press
GENEVA (AP) - Scientists at the world's biggest atom smasher hailed the discovery of "the missing cornerstone of physics" Wednesday, cheering the apparent end of a decades-long quest for a new subatomic particle called the Higgs boson, or "
By MATTHEW PERRONEAP Health Writer
WASHINGTON (AP) - Metal hip replacements implanted in a half-million Americans may be failing earlier than expected, but it could be years before U.S. health regulators have a clear picture of the problem.
The Food and Drug